Phase 3
New DARZALEX® (daratumumab) Phase 3 Study Shows Efficacy and Safety Data of Anti-CD38 Monoclonal Antibody in Patients with Newly Diagnosed Multiple Myeloma
Janssen Pharmaceutical Companies
PR-M12-18-NI-019Dec 06, 2018
Clinical Trials
Phase III Study Results for Peanut Allergy Therapy Are a Mixed Bag
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M11-18-NI-021Nov 20, 2018
Clinical Trials
Regenera Pharma Enrolls First Patient in US Phase 3 Study of RPh201 in NAION, Advances Phase 2 Study in Alzheimer's Disease in Canada
Regenera Pharma
PR-M08-18-NI-038Aug 10, 2018